vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.
ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $123.8M, roughly 2.0× NATURES SUNSHINE PRODUCTS INC). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs 3.3%, a 1.7% gap on every dollar of revenue. On growth, ONESPAWORLD HOLDINGS Ltd posted the faster year-over-year revenue change (11.5% vs 4.7%). ONESPAWORLD HOLDINGS Ltd produced more free cash flow last quarter ($14.9M vs $7.6M). Over the past eight quarters, ONESPAWORLD HOLDINGS Ltd's revenue compounded faster (7.1% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
NATR vs OSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $242.1M |
| Net Profit | $4.1M | $12.1M |
| Gross Margin | 72.5% | — |
| Operating Margin | 4.3% | 6.8% |
| Net Margin | 3.3% | 5.0% |
| Revenue YoY | 4.7% | 11.5% |
| Net Profit YoY | 1379.4% | -16.2% |
| EPS (diluted) | $0.23 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $242.1M | ||
| Q3 25 | $128.3M | $258.5M | ||
| Q2 25 | $114.8M | $240.7M | ||
| Q1 25 | $113.2M | $219.6M | ||
| Q4 24 | $118.2M | $217.2M | ||
| Q3 24 | $114.6M | $241.7M | ||
| Q2 24 | $110.6M | $224.9M | ||
| Q1 24 | $111.0M | $211.2M |
| Q4 25 | $4.1M | $12.1M | ||
| Q3 25 | $5.3M | $24.3M | ||
| Q2 25 | $5.3M | $19.9M | ||
| Q1 25 | $4.7M | $15.3M | ||
| Q4 24 | $-321.0K | $14.4M | ||
| Q3 24 | $4.3M | $21.6M | ||
| Q2 24 | $1.3M | $15.8M | ||
| Q1 24 | $2.3M | $21.2M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 6.8% | ||
| Q3 25 | 7.0% | 10.2% | ||
| Q2 25 | 3.7% | 9.2% | ||
| Q1 25 | 5.4% | 7.7% | ||
| Q4 24 | 3.8% | 7.9% | ||
| Q3 24 | 4.6% | 10.3% | ||
| Q2 24 | 5.1% | 8.4% | ||
| Q1 24 | 4.2% | 8.0% |
| Q4 25 | 3.3% | 5.0% | ||
| Q3 25 | 4.2% | 9.4% | ||
| Q2 25 | 4.6% | 8.3% | ||
| Q1 25 | 4.2% | 7.0% | ||
| Q4 24 | -0.3% | 6.6% | ||
| Q3 24 | 3.8% | 8.9% | ||
| Q2 24 | 1.2% | 7.0% | ||
| Q1 24 | 2.1% | 10.0% |
| Q4 25 | $0.23 | $0.12 | ||
| Q3 25 | $0.30 | $0.23 | ||
| Q2 25 | $0.28 | $0.19 | ||
| Q1 25 | $0.25 | $0.15 | ||
| Q4 24 | $-0.02 | $0.13 | ||
| Q3 24 | $0.23 | $0.20 | ||
| Q2 24 | $0.07 | $0.15 | ||
| Q1 24 | $0.12 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $16.3M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $161.6M | $542.6M |
| Total Assets | $261.1M | $707.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $16.3M | ||
| Q3 25 | $95.6M | $29.6M | ||
| Q2 25 | $81.3M | $35.0M | ||
| Q1 25 | $86.5M | $22.6M | ||
| Q4 24 | $84.7M | $57.4M | ||
| Q3 24 | $78.7M | $48.8M | ||
| Q2 24 | $68.7M | $62.5M | ||
| Q1 24 | $77.8M | $65.4M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | $2.1M | $138.6M |
| Q4 25 | $161.6M | $542.6M | ||
| Q3 25 | $166.7M | $552.8M | ||
| Q2 25 | $163.7M | $548.3M | ||
| Q1 25 | $167.1M | $530.6M | ||
| Q4 24 | $161.0M | $554.5M | ||
| Q3 24 | $162.6M | $540.1M | ||
| Q2 24 | $156.4M | $532.7M | ||
| Q1 24 | $159.7M | $515.5M |
| Q4 25 | $261.1M | $707.1M | ||
| Q3 25 | $264.8M | $732.6M | ||
| Q2 25 | $254.9M | $731.8M | ||
| Q1 25 | $252.7M | $708.7M | ||
| Q4 24 | $240.9M | $746.4M | ||
| Q3 24 | $245.3M | $734.0M | ||
| Q2 24 | $235.8M | $756.8M | ||
| Q1 24 | $247.3M | $763.6M |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | 0.01× | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $20.0M |
| Free Cash FlowOCF − Capex | $7.6M | $14.9M |
| FCF MarginFCF / Revenue | 6.1% | 6.2% |
| Capex IntensityCapex / Revenue | 1.9% | 2.1% |
| Cash ConversionOCF / Net Profit | 2.41× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $68.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $20.0M | ||
| Q3 25 | $18.5M | $33.2M | ||
| Q2 25 | $4.3M | $20.3M | ||
| Q1 25 | $2.6M | $10.1M | ||
| Q4 24 | $12.2M | $16.6M | ||
| Q3 24 | $9.6M | $28.6M | ||
| Q2 24 | $1.3M | $18.7M | ||
| Q1 24 | $2.2M | $15.0M |
| Q4 25 | $7.6M | $14.9M | ||
| Q3 25 | $16.8M | $27.6M | ||
| Q2 25 | $3.0M | $17.6M | ||
| Q1 25 | $1.5M | $8.4M | ||
| Q4 24 | $10.0M | $13.2M | ||
| Q3 24 | $7.9M | $27.5M | ||
| Q2 24 | $-2.0M | $17.6M | ||
| Q1 24 | $-1.5M | $13.7M |
| Q4 25 | 6.1% | 6.2% | ||
| Q3 25 | 13.1% | 10.7% | ||
| Q2 25 | 2.6% | 7.3% | ||
| Q1 25 | 1.3% | 3.8% | ||
| Q4 24 | 8.5% | 6.1% | ||
| Q3 24 | 6.9% | 11.4% | ||
| Q2 24 | -1.9% | 7.8% | ||
| Q1 24 | -1.4% | 6.5% |
| Q4 25 | 1.9% | 2.1% | ||
| Q3 25 | 1.3% | 2.2% | ||
| Q2 25 | 1.2% | 1.1% | ||
| Q1 25 | 1.0% | 0.8% | ||
| Q4 24 | 1.9% | 1.5% | ||
| Q3 24 | 1.5% | 0.5% | ||
| Q2 24 | 3.0% | 0.5% | ||
| Q1 24 | 3.3% | 0.6% |
| Q4 25 | 2.41× | 1.65× | ||
| Q3 25 | 3.46× | 1.36× | ||
| Q2 25 | 0.81× | 1.02× | ||
| Q1 25 | 0.55× | 0.66× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | 2.21× | 1.33× | ||
| Q2 24 | 0.97× | 1.19× | ||
| Q1 24 | 0.94× | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
